Cancer discovery
Xiao Y, Freeman GJ.
PMID: 25583798
Cancer Discov. 2015 Jan;5(1):16-8. doi: 10.1158/2159-8290.CD-14-1397.
The microsatellite instable (MSI) subset of colorectal cancer exhibits an active Th1/CTL immune microenvironment, probably due to recognition of a high number of tumor neoantigens. However, the high expression of checkpoint molecules PD-1, PD-L1, CTLA-4, LAG-3, and IDO in...
Cite
Xiao Y, Freeman GJ. The microsatellite instable subset of colorectal cancer is a particularly good candidate for checkpoint blockade immunotherapy. Cancer Discov. 2015;5(1):16-8doi: 10.1158/2159-8290.CD-14-1397.
Xiao, Y., & Freeman, G. J. (2015). The microsatellite instable subset of colorectal cancer is a particularly good candidate for checkpoint blockade immunotherapy. Cancer discovery, 5(1), 16-8. https://doi.org/10.1158/2159-8290.CD-14-1397
Xiao, Yanping, and Freeman, Gordon J. "The microsatellite instable subset of colorectal cancer is a particularly good candidate for checkpoint blockade immunotherapy." Cancer discovery vol. 5,1 (2015): 16-8. doi: https://doi.org/10.1158/2159-8290.CD-14-1397
Xiao Y, Freeman GJ. The microsatellite instable subset of colorectal cancer is a particularly good candidate for checkpoint blockade immunotherapy. Cancer Discov. 2015 Jan;5(1):16-8. doi: 10.1158/2159-8290.CD-14-1397. PMID: 25583798; PMCID: PMC4295637.
Copy
Download .nbib
